466 related articles for article (PubMed ID: 19039139)
1. PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release.
Singh R; Manjunatha U; Boshoff HI; Ha YH; Niyomrattanakit P; Ledwidge R; Dowd CS; Lee IY; Kim P; Zhang L; Kang S; Keller TH; Jiricek J; Barry CE
Science; 2008 Nov; 322(5906):1392-5. PubMed ID: 19039139
[TBL] [Abstract][Full Text] [Related]
2. Microbiology. An antibiotic mimics immunity.
Nathan C
Science; 2008 Nov; 322(5906):1337-8. PubMed ID: 19039126
[No Abstract] [Full Text] [Related]
3. Structure-activity relationships of antitubercular nitroimidazoles. 1. Structural features associated with aerobic and anaerobic activities of 4- and 5-nitroimidazoles.
Kim P; Zhang L; Manjunatha UH; Singh R; Patel S; Jiricek J; Keller TH; Boshoff HI; Barry CE; Dowd CS
J Med Chem; 2009 Mar; 52(5):1317-28. PubMed ID: 19209889
[TBL] [Abstract][Full Text] [Related]
4. Substrate specificity of the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis responsible for the bioreductive activation of bicyclic nitroimidazoles.
Gurumurthy M; Mukherjee T; Dowd CS; Singh R; Niyomrattanakit P; Tay JA; Nayyar A; Lee YS; Cherian J; Boshoff HI; Dick T; Barry CE; Manjunatha UH
FEBS J; 2012 Jan; 279(1):113-25. PubMed ID: 22023140
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal activity of PA-824 against Mycobacterium tuberculosis under anaerobic conditions and computational analysis of its novel analogues against mutant Ddn receptor.
Somasundaram S; Anand RS; Venkatesan P; Paramasivan CN
BMC Microbiol; 2013 Oct; 13():218. PubMed ID: 24083570
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of antitubercular nitroimidazoles. 3. Exploration of the linker and lipophilic tail of ((s)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-amino PA-824).
Cherian J; Choi I; Nayyar A; Manjunatha UH; Mukherjee T; Lee YS; Boshoff HI; Singh R; Ha YH; Goodwin M; Lakshminarayana SB; Niyomrattanakit P; Jiricek J; Ravindran S; Dick T; Keller TH; Dartois V; Barry CE
J Med Chem; 2011 Aug; 54(16):5639-59. PubMed ID: 21755942
[TBL] [Abstract][Full Text] [Related]
7. Structure of Ddn, the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis involved in bioreductive activation of PA-824.
Cellitti SE; Shaffer J; Jones DH; Mukherjee T; Gurumurthy M; Bursulaya B; Boshoff HI; Choi I; Nayyar A; Lee YS; Cherian J; Niyomrattanakit P; Dick T; Manjunatha UH; Barry CE; Spraggon G; Geierstanger BH
Structure; 2012 Jan; 20(1):101-12. PubMed ID: 22244759
[TBL] [Abstract][Full Text] [Related]
8. Comparative bioactivation of the novel anti-tuberculosis agent PA-824 in Mycobacteria and a subcellular fraction of human liver.
Dogra M; Palmer BD; Bashiri G; Tingle MD; Shinde SS; Anderson RF; O'Toole R; Baker EN; Denny WA; Helsby NA
Br J Pharmacol; 2011 Jan; 162(1):226-36. PubMed ID: 20955364
[TBL] [Abstract][Full Text] [Related]
9. The effect of 5-substitution on the electrochemical behavior and antitubercular activity of PA-824.
Bollo S; Núñez-Vergara LJ; Kang S; Zhang L; Boshoff HI; Barry CE; Squella JA; Dowd CS
Bioorg Med Chem Lett; 2011 Jan; 21(2):812-7. PubMed ID: 21168331
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of 5-nitrothiophenes against Mycobacterium tuberculosis.
Hartkoorn RC; Ryabova OB; Chiarelli LR; Riccardi G; Makarov V; Cole ST
Antimicrob Agents Chemother; 2014 May; 58(5):2944-7. PubMed ID: 24550336
[TBL] [Abstract][Full Text] [Related]
11. Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis.
Manjunatha UH; Boshoff H; Dowd CS; Zhang L; Albert TJ; Norton JE; Daniels L; Dick T; Pang SS; Barry CE
Proc Natl Acad Sci U S A; 2006 Jan; 103(2):431-6. PubMed ID: 16387854
[TBL] [Abstract][Full Text] [Related]
12. The nitroimidazooxazines (PA-824 and analogs): structure-activity relationship and mechanistic studies.
Denny WA; Palmer BD
Future Med Chem; 2010 Aug; 2(8):1295-304. PubMed ID: 21426020
[TBL] [Abstract][Full Text] [Related]
13. New Insights into the Mechanism of Action of the Thienopyrimidine Antitubercular Prodrug TP053.
Chiarelli LR; Salina EG; Mori G; Azhikina T; Riabova O; Lepioshkin A; Grigorov A; Forbak M; Madacki J; Orena BS; Manfredi M; Gosetti F; Buzzi A; Degiacomi G; Sammartino JC; Marengo E; Korduláková J; Riccardi G; Mikušová K; Makarov V; Pasca MR
ACS Infect Dis; 2020 Feb; 6(2):313-323. PubMed ID: 31729215
[TBL] [Abstract][Full Text] [Related]
14. 2-((3,5-Dinitrobenzyl)thio)quinazolinones: Potent Antimycobacterial Agents Activated by Deazaflavin (F
Jian Y; Forbes HE; Hulpia F; Risseeuw MDP; Caljon G; Munier-Lehmann H; Boshoff HIM; Van Calenbergh S
J Med Chem; 2021 Jan; 64(1):440-457. PubMed ID: 33347317
[TBL] [Abstract][Full Text] [Related]
15. Mutations in genes for the F420 biosynthetic pathway and a nitroreductase enzyme are the primary resistance determinants in spontaneous in vitro-selected PA-824-resistant mutants of Mycobacterium tuberculosis.
Haver HL; Chua A; Ghode P; Lakshminarayana SB; Singhal A; Mathema B; Wintjens R; Bifani P
Antimicrob Agents Chemother; 2015 Sep; 59(9):5316-23. PubMed ID: 26100695
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosis.
Fujiwara M; Kawasaki M; Hariguchi N; Liu Y; Matsumoto M
Tuberculosis (Edinb); 2018 Jan; 108():186-194. PubMed ID: 29523322
[TBL] [Abstract][Full Text] [Related]
17. Predicting nitroimidazole antibiotic resistance mutations in Mycobacterium tuberculosis with protein engineering.
Lee BM; Harold LK; Almeida DV; Afriat-Jurnou L; Aung HL; Forde BM; Hards K; Pidot SJ; Ahmed FH; Mohamed AE; Taylor MC; West NP; Stinear TP; Greening C; Beatson SA; Nuermberger EL; Cook GM; Jackson CJ
PLoS Pathog; 2020 Feb; 16(2):e1008287. PubMed ID: 32032366
[TBL] [Abstract][Full Text] [Related]
18. Molecular dynamic assisted investigation on impact of mutations in deazaflavin dependent nitroreductase against pretomanid: a computational study.
Singh R; Shaheer M; Sobhia ME
J Biomol Struct Dyn; 2023 Jul; 41(10):4421-4443. PubMed ID: 35574601
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, structure and biological evaluation of novel bicyclic nitroimidazole derivatives.
Zaprutko L; Zwawiak J; Augustynowicz-Kopeć E; Zwolska Z; Bartoszak-Adamska E; Nowicki W
Arch Pharm (Weinheim); 2012 Jun; 345(6):463-7. PubMed ID: 22266946
[TBL] [Abstract][Full Text] [Related]
20. Nitroreductase-activated nitric oxide (NO) prodrugs.
Sharma K; Sengupta K; Chakrapani H
Bioorg Med Chem Lett; 2013 Nov; 23(21):5964-7. PubMed ID: 24050886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
